Of note, a study of 386 patients with MDS demonstrated that SETBP1 mutation enhances the expression of mutant ASXL1 and plays a pivotal role in the leukemic transformation from MDS to AML76. The gene discussed is ASXL1; the disease is myelodysplastic syndrome.